{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/d216e525-3568-4f94-b402-8a3eaa1ad260/62ebfc7d9c12600011c35d55?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Are ancillary studies of any utility in risk assessment of Barrett’s esophagus and dysplasia? ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9f39f1a8cbe7bbf3cedc6/show-cover.png?height=200","description":"<p><em>Modern Pathology</em> have recently launched a new series of reviews addressing controversial issues in pathology. In this episode of ModPath CHAT, Dr. Elizabeth Montgomery, a world renowned expert in gastrointestinal pathology gives her point of view on the utility of ancillary testing for risk stratification of Barrett’s esophagus and dysplasia.&nbsp;</p>","author_name":"Modern Pathology"}